Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00361699
Status:
COMPLETED
Last Update Posted:
2016-04-25
First Post:
2006-08-07
Brief Title:
hsCRP in Japan Statin Treatment Against Recurrent Stroke J-STARS hsCRP
Sponsor:
Translational Research Center for Medical Innovation Kobe Hyogo Japan
Organization:
Translational Research Center for Medical Innovation Kobe Hyogo Japan
Study Overview
Official Title:
Effect of 3-hydroxy-3-methylglutaryl-coenzyme AHMG-CoA Reductase Inhibitor Upon the Serum High Sensitive CRP in the Post-ischemic Patients With Hyperlipidemia During the Prospective Study of J-STARS
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme AHMG-CoA reductase can play a role in preventing recurrent vascular events from ischemic heart disease patients whose mechanism consists in not only the reduction of serum lipid level but also anti-inflammatory effects Serum high sensitive CRP is known to be a predictor of cardiovascular events independent of other conventional risk factors The present substudy examine whether such pleiotrophic effect of HMG-CoA reductase inhibitor statin which decreases high sensitive CRP would be observed in the post-ischemic stroke patients who have already been registered in the J-STARS and the relationship the values of high sensitive CRP and recurrence of stroke
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| C000000211 | OTHER | UMIN CTR | None |